1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Strategy

P&G Extends Oral-B Brush Line With iOSense

Partners With Grin Tele-Dentistry Platform, Dusts Off Crest Defenders Campaign

 
• By Malcolm Spicer

Brush “provides live coaching” through embedded iOSense Charger to guide time, pressure and coverage without needing to watch smartphone app. Firm also extending Oral-B iO lineup with lower-priced iO4 and iO5 brushes available nationwide in the US beginning later in 2022.

• Source: Alamy

Procter & Gamble didn’t wait long in 2022 to announce Oral-B brand line extensions, though it’s starting with a waiting list for an electric toothbrush with digital sensors to guide care and will offer additional lower-priced brushes later in the year.

The global consumer health, personal and household care products manufacturer and marketer announced on 4 January that its Oral-B iO10 brush with iOSense technology is a Consumer Electronics Show 2022...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

Alliance Pharma’s New Owners Will Instill ‘More Consumer-Oriented Mindset’

 
• By Tom Gallen

Private equity firms now in control of Alliance Pharma weighing úp plan to offload Rx business to help finance strategy to drive up sales and growth.

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By Tom Gallen

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Over The Counter: Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer

 
• By David Ridley

In part 2 of HBW Insight's interview, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, explains how to approach real world evidence so that regulators recognize its validity, in supporting Rx-to-OTC switch applications, for example.

Recordati Relying On OTC To Act As ‘Booster’ To Growth

 
• By Tom Gallen

In categories like cough & cold and gastrointestinal, OTC products have a pivotal role to play in helping Recordati hit its sales targets for the 2025-2027 period.

More from Business

Bayer Consumer Health Delivers ‘Balanced’ Q1

 
• By Tom Gallen

With sales gains across most of its regions and product categories, Bayer Consumer Health got off to a good start to the year.

People On The Move: Appointments at Opella, NèreS, Haleon

 
• By Tom Gallen

A round-up of the latest consumer health industry moves: Opella names France head; NèreS elects president; Haleon has new Saudi GM.

C&D Taps Hand Sanitizer Category With Touchland

 
• By Malcolm Spicer

Deal totaling as much as $880m extends C&D into additional product category with a brand it says is the fastest growing in the US hand sanitizer category and No. 2 brand in the category overall.